| Application no. and date | 99916907.1 (espacenet) (Federated) (European Patent Register), 19990326 | | Patent/reg. no. and date | DK/EP 1063995, 20030115 | | Publication date | 20010103 | | Priority no. and date | EP 98400723, 19980326 | | EP pub. no. and date |
EP 1063995 20010103 | | Effective date | | | Applicant/owner | Merck Sante, 37, rue Saint Romain
69008 Lyon, FR | | Applicant ref. no. | 32983 DK 01 | | Inventor | DAOUST, Martine, 7, allée Alphonse Daudet
F-76690 Nôtre Dame de Bondeville, FR,
BONHOMME, Yves Le Buclay, 21, avenue de la Paix
F-69260 Charbonnières Les Bains, FR,
DURBIN, Philippe, 83, rue Paul Verlaine
F-69100 Villeurbanne, FR | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/485 | | Title | Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator | | Int. application no. | EP1999002337 | | Int. publication no. | WO1999048500 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
